Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients
Kaori Sakaizawa(Shinshu University), Hisashi Uhara(Sapporo Medical University), Shigeto Matsushita, Naohito Hatta(Toyama Prefectural Central Hospital), Yasuhiro Fujisawa(University of Tsukuba), Takamichi Ito(Kyushu University), Ryuhei Okuyama(Shinshu University Hospital), Jiro Uehara(Asahikawa Medical University), Aya Uchiyama(Shinshu University), Atsuko Ashida(Ōtani University), Tatsuya Takenouchi(Niigata Cancer Center Hospital), Dai Ogata(University of Miyazaki), Kazuyasu Fujii(Kagoshima University), Naoya Yamazaki, Yoshitsugu Shibayama(Fukuoka University), Satoshi Fukushima(Niigata Cancer Center Hospital)
Cited by 120
Related Papers
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
|Nature Immunology|2020|810
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338
High Commitment of Embryonic Keratinocytes to Terminal Differentiation through a Notch1-caspase 3 Regulatory Mechanism
|Developmental Cell|2004|186
Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases
|Journal of Dermatological Science|2007|163